HomeCMPX • NASDAQ
add
Compass Therapeutics Inc.
Previous close
$1.57
Day range
$1.62 - $1.69
Year range
$1.15 - $3.62
Market cap
231.14M USD
Avg Volume
316.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 15.39M | 19.44% |
Net income | -13.42M | -15.71% |
Net profit margin | — | — |
Earnings per share | -0.11 | -10.00% |
EBITDA | -15.23M | -20.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 152.46M | -18.30% |
Total assets | 156.88M | -21.42% |
Total liabilities | 8.34M | -53.70% |
Total equity | 148.54M | — |
Shares outstanding | 137.59M | — |
Price to book | 1.35 | — |
Return on assets | -23.54% | — |
Return on capital | -24.64% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -13.42M | -15.71% |
Cash from operations | -12.35M | -16.10% |
Cash from investing | 6.31M | 113.54% |
Cash from financing | -158.00K | -100.21% |
Net change in cash | -6.20M | -133.57% |
Free cash flow | -7.45M | -18.94% |
About
Founded
2014
Headquarters
Website
Employees
32